RESEARCHERS have developed a unique antimicrobial hydrogel that may make patient deaths from hospital acquired infections and superbugs a thing of the past.
These infections, such as MRSA and E. coli, have often been stubbornly resistant to antibiotic treatment. Tests done by the National University Hospital have shown that infected patients here were 10 times more likely to die and spent nearly five times as long in hospital during hospitalisation compared to patients who were not infected.
